Center for Biomedical Research, The University of Texas Health Center at Tyler, 75708-3154, USA.
Am J Physiol Lung Cell Mol Physiol. 2011 Oct;301(4):L427-40. doi: 10.1152/ajplung.00090.2011. Epub 2011 Jul 22.
Thyroid transcription factor-1 (TTF-1/Nkx2.1/TITF1) is a homeodomain-containing transcription factor essential for the morphogenesis and differentiation of the lung. In the lung, TTF-1 controls the expression of surfactant proteins that are essential for lung stability and lung host defense. In this study, we identified functionally important transcription factor binding sites in the TTF-1 proximal promoter and studied tumor necrosis factor-α (TNF-α) regulation of TTF-1 expression. TNF-α, a proinflammatory cytokine, has been implicated in the pathogenesis of acute respiratory distress syndrome (ARDS) and inhibits surfactant protein levels. Deletion analysis of TTF-1 5'-flanking DNA indicated that the TTF-1 proximal promoter retained high-level activity. Electrophoretic mobility shift assay, chromatin immunoprecipitation, and mutational analysis experiments identified functional ZBP-89, Sp1, Sp3, and TTF-1 sites in the TTF-1 proximal promoter. TNF-α inhibited TTF-1 protein levels in H441 and primary alveolar type II cells. TNF-α inhibited TTF-1 gene transcription and promoter activity, indicating that transcriptional mechanisms play important roles in the inhibition of TTF-1 levels. TNF-α inhibited TTF-1 but not Sp1 or hepatocyte nuclear factor-3 DNA binding to TTF-1 promoter. Transactivation experiments in A549 cells indicated that TNF-α inhibited TTF-1 promoter activation by exogenous Sp1 and TTF-1 without altering their levels, suggesting inhibition of transcriptional activities of these proteins. TNF-α inhibition of TTF-1 expression was associated with increased threonine, but not serine, phosphorylation of Sp1. Because TTF-1 serves as a positive regulator for surfactant protein gene expression, TNF-α inhibition of TTF-1 expression could have important implications for the reduction of surfactant protein levels in diseases such as ARDS.
甲状腺转录因子-1(TTF-1/Nkx2.1/TITF1)是一种含同源结构域的转录因子,对于肺的形态发生和分化至关重要。在肺中,TTF-1 控制着表面活性剂蛋白的表达,这些蛋白对于肺的稳定性和肺宿主防御至关重要。在这项研究中,我们鉴定了 TTF-1 近端启动子中功能重要的转录因子结合位点,并研究了肿瘤坏死因子-α(TNF-α)对 TTF-1 表达的调节。TNF-α,一种促炎细胞因子,与急性呼吸窘迫综合征(ARDS)的发病机制有关,并抑制表面活性剂蛋白水平。TTF-1 5'侧翼 DNA 的缺失分析表明,TTF-1 近端启动子保留了高水平的活性。电泳迁移率变动分析、染色质免疫沉淀和突变分析实验鉴定了 TTF-1 近端启动子中的功能 ZBP-89、Sp1、Sp3 和 TTF-1 位点。TNF-α抑制 H441 和原代肺泡型 II 细胞中的 TTF-1 蛋白水平。TNF-α抑制 TTF-1 基因转录和启动子活性,表明转录机制在 TTF-1 水平的抑制中发挥重要作用。TNF-α抑制 TTF-1 但不抑制 Sp1 或肝细胞核因子-3 DNA 与 TTF-1 启动子的结合。A549 细胞中的转激活实验表明,TNF-α通过外源性 Sp1 和 TTF-1 抑制 TTF-1 启动子的激活,而不改变它们的水平,这表明抑制这些蛋白的转录活性。TNF-α抑制 TTF-1 表达与 Sp1 的丝氨酸而非苏氨酸磷酸化增加有关。由于 TTF-1 是表面活性剂蛋白基因表达的正调节因子,因此 TNF-α抑制 TTF-1 表达可能对 ARDS 等疾病中表面活性剂蛋白水平的降低具有重要意义。